Synthon Bv competitive analysis

Explore patent oppositions filed by Synthon Bv against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition Date
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 20, 2026
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofF HOFFMANN LA ROCHEJun 9, 2026
Methods For Treating HyperphenylalaninemiaPTC THERAPEUTICS MPMay 10, 2026
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKMay 5, 2026
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMar 11, 2026
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISJan 23, 2026
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforCRYSTAL PHARMACEUTICAL SUZHOUDec 19, 2025
Methods For Treating Hypertrophic CardiomyopathyCYTOKINETICSOct 14, 2025
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 14, 2025

Explore Synthon Bv's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 20, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 19, 2025Pharmaceutical Composition Comprising Enzalutamide1
Mar 2, 2022Process For Making Sugammadex2
Apr 29, 2020Crystalline Form Ii Of Anagrelide Hydrochloride Monohydrate1
Dec 11, 2019Liquid Pharmaceutical Composition Comprising Pemetrexed1
Jul 17, 2019Process For Making Fingolimod Hydrochloride Crystals1
Jul 3, 2019Process For Making Fingolimod Hydrochloride Crystals1

Latest PTAB cases involving Synthon Bv

Discover the latest PTAB cases involving Synthon Bv, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Synthon Bv with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SYNTHON4019 - -
ARAGON PHARMACEUTICALS - 25 - -
ARENA PHARMACEUTICALS - 18 - -
NOVARTIS6475 - 21